NCT00448227 - Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2008

Conditions

Herpes Simplex

Interventions

DRUG

famciclovir

Administered orally as a single individualized dose between 25-200 mg based on body weight.

Trial Locations (6)

Archana Chatterjee, Omaha

Pediatric Infectious Disease Of University of Alabama, Birmingham

Children's Memorial Hospital Chicago, Chicago

Children's Hospital of Michigan, Detroit

University Hospital Cased Medical Center Rainbow Babies and Children's Hospital, Cleveland

UT Southwestern Medical Center, Dallas